Anionic Drug Delivery
with
Precision & Efficiency
high cell transfection / cell entry without associated toxicity
self-assembly with almost any anionic therapeutic cargo
consistent and stable nanoparticles allow scale-up
non-immunogenic nanoparticles allow repeated dosing
protection of drug cargo while increasing circulatory half-life
demonstrated formulation lyophilsation and scale-up
strong IP protection as the only peptide drug delivery system
RALA represents a revolution in nanoparticle therapeutic delivery by starting with peptides.
RALA peptide nanoparticles have many advantages:
All you need to know is that RALA is a 30 amino acid, pH responsive, cationic, secondary amphipathic, helical, conditional cell penetrating peptide. In other words... one peptide with all the functions needed for a revolution in drug delivery!
Learn more by clicking below on one of our informative and downloadable files.
Click here
to learn more
Learn About
RALA Nanoparticles
Learn About Cargo
and Tissue Capabilities
Learn About
Tumour Targeting
Small // Stable // Self-Assembling
RALA Peptide : POSITIVE CHARGES
Drug Cargo : NEGATIVE CHARGES
(e.g. DNA, RNA, or Small Molecules)
SELF-ASSEMBLY OF ION PAIRS
Forms Consistent & Stable Nanoparticles
Regardless of Cargo Type
Z-Average
< 100 nm